EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totaling 10,575 shares, an increase of 46.1% from the December 31st total of 7,240 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 198,536 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 198,536 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company’s stock are sold short.

Analysts Set New Price Targets

Several research firms have recently weighed in on ESLOY. Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Finally, HSBC raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy”.

EssilorLuxottica Stock Performance

Shares of EssilorLuxottica stock opened at $152.77 on Friday. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18. EssilorLuxottica has a 12-month low of $126.47 and a 12-month high of $186.81. The business’s 50 day moving average is $163.80 and its 200-day moving average is $162.85.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.